CoChat

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation

Open access

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Abstract

Activation of the NLRP3 inflammasome by microbial ligands or tissue damage requires intracellular generation of reactive oxygen species (ROS). We present evidence that macrophage secretion of IL1β upon stimulation with ATP, crystals or LPS is mediated by a rapid increase in the activity of xanthine oxidase (XO), the oxidized form of xanthine dehydrogenase, resulting in the formation of uric acid as well as ROS. We show that XO-derived ROS, but not uric acid, is the trigger for IL1β release and that XO blockade results in impaired IL1β and caspase1 secretion. XO is localized to both cytoplasmic and mitochondrial compartments and acts upstream to the PI3K–AKT signalling pathway that results in mitochondrial ROS generation. This pathway represents a mechanism for regulating NLRP3 inflammasome activation that may have therapeutic implications in inflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms7555

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 XOR is involved in caspase1-dependent secretion of IL1β in macrophages stimulated with microcrystals. In vitro C57BL/6 BMDM (Pam3Cys (P3C) or LPSup primed), and THP1 (PMA primed) were stimulated with OCP and MSU at 250 μg ml−1, Alum-500 μg ml−1 and HZ-200 μg ml−1. IL1β protein was measured by ELISA in supernatants; intracellular XO and UA measured on protein extracts by activity tests. (a) Upper panel: P3C primed, OCP-stimulated BMDM. Lower panel: In vivo OCP-induced peritonitis. Levels of IL1β, XO and UA measured in peritoneal washes of individual mice. (b) XO activity measured in LPSup primed, crystal-stimulated BMDM at 2 h. (c) IL1β measured in XOR siRNA, or control NegSiRNA-transfected BMDM that were P3C primed. (d) BMDM were pretreated with XOR inhibitors (Allopurinol 250 g ml−1, Febuxostat 200 μM) and Apocynin (2.5 mM), extracellular IL1β protein levels quantified and expressed as percentage of stimulation of inhibitor-treated versus non-treated cells. (e) Protein sizes of proCaspase1 and proIL1β in cell extracts (CEs), and active IL1β in the supernatants (spts) by western blot, secreted IL1β and caspase1 by ELISA. (f) In vivo, mice were pretreated with Allopurinol—500 μg per mouse 30 min prior to OCP-1 mg per mouse or PBS control intraperitoneal injection. After 6 h, peritoneal washes were obtained (two pooled experiments). Viable cells were counted and urate, and IL1β measured. Unless stated, experiments were performed at 6 h and data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance (b,d–f) or the t-test (a,c). NP, not performed; NS, not significant.
Figure 1 XOR is involved in caspase1-dependent secretion of IL1β in macrophages stimulated with microcrystals. In vitro C57BL/6 BMDM (Pam3Cys (P3C) or LPSup primed), and THP1 (PMA primed) were stimulated with OCP and MSU at 250 μg ml−1, Alum-500 μg ml−1 and HZ-200 μg ml−1. IL1β protein was measured by ELISA in supernatants; intracellular XO and UA measured on protein extracts by activity tests. (a) Upper panel: P3C primed, OCP-stimulated BMDM. Lower panel: In vivo OCP-induced peritonitis. Levels of IL1β, XO and UA measured in peritoneal washes of individual mice. (b) XO activity measured in LPSup primed, crystal-stimulated BMDM at 2 h. (c) IL1β measured in XOR siRNA, or control NegSiRNA-transfected BMDM that were P3C primed. (d) BMDM were pretreated with XOR inhibitors (Allopurinol 250 g ml−1, Febuxostat 200 μM) and Apocynin (2.5 mM), extracellular IL1β protein levels quantified and expressed as percentage of stimulation of inhibitor-treated versus non-treated cells. (e) Protein sizes of proCaspase1 and proIL1β in cell extracts (CEs), and active IL1β in the supernatants (spts) by western blot, secreted IL1β and caspase1 by ELISA. (f) In vivo, mice were pretreated with Allopurinol—500 μg per mouse 30 min prior to OCP-1 mg per mouse or PBS control intraperitoneal injection. After 6 h, peritoneal washes were obtained (two pooled experiments). Viable cells were counted and urate, and IL1β measured. Unless stated, experiments were performed at 6 h and data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance (b,d–f) or the t-test (a,c). NP, not performed; NS, not significant.CC BY · PubMed Central
Figure 2 Urate generated by XOR is not the mediator of inflammasome responses in crystal-stimulated macrophages. (a,b) In vitro C57BL/6 or intUOX-Tg-derived BMDM (Pam3Cys primed), pretreated with uricase—10 μg ml−1 and XOR inhibitor febuxostat—200 μM, were stimulated with OCP or MSU at 250 μg ml−1, Alum-500 μg ml−1, HZ-200 μg ml−1 or soluble urate at 600 μM. Experiments were performed at 6 h; data are representative of at least two experiments. (c) Mice were pretreated with uricase—20 μg per mouse. OCP or PBS injected. After 6 h, peritoneal washes were obtained, viable cells counted, and urate and IL1β measured in cell-free washes (two pooled experiments). Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance. ND, not detectable; NS, not significant.
Figure 2 Urate generated by XOR is not the mediator of inflammasome responses in crystal-stimulated macrophages. (a,b) In vitro C57BL/6 or intUOX-Tg-derived BMDM (Pam3Cys primed), pretreated with uricase—10 μg ml−1 and XOR inhibitor febuxostat—200 μM, were stimulated with OCP or MSU at 250 μg ml−1, Alum-500 μg ml−1, HZ-200 μg ml−1 or soluble urate at 600 μM. Experiments were performed at 6 h; data are representative of at least two experiments. (c) Mice were pretreated with uricase—20 μg per mouse. OCP or PBS injected. After 6 h, peritoneal washes were obtained, viable cells counted, and urate and IL1β measured in cell-free washes (two pooled experiments). Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance. ND, not detectable; NS, not significant.CC BY · PubMed Central
Figure 3 Crystal-induced IL1β secretion is mediated by ROS. In vitro BMDM (Pam3Cys primed) were pretreated with XOR inhibitors: febuxostat, 200 μM and allopurinol, 500 μg ml−1 and stimulated with OCP or MSU at 250 μg ml−1, Alum-500 μg ml−1 and HZ-200 μg ml−1. (a) Superoxide was measured with dihydroethidium (DHE), results expressed as fold increase in relative fluorescence units (RFUs) at T=120 min over T=0. (b) ROS measured by luminol, data obtained by relative luminescence units (RLUs) at T=60 min. Data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by the t-test for all panels.
Figure 3 Crystal-induced IL1β secretion is mediated by ROS. In vitro BMDM (Pam3Cys primed) were pretreated with XOR inhibitors: febuxostat, 200 μM and allopurinol, 500 μg ml−1 and stimulated with OCP or MSU at 250 μg ml−1, Alum-500 μg ml−1 and HZ-200 μg ml−1. (a) Superoxide was measured with dihydroethidium (DHE), results expressed as fold increase in relative fluorescence units (RFUs) at T=120 min over T=0. (b) ROS measured by luminol, data obtained by relative luminescence units (RLUs) at T=60 min. Data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by the t-test for all panels.CC BY · PubMed Central
Figure 4 XOR was not modulated at RNA and protein levels. In vitro C57BL/6 BMDM (Pam3Cys (P3C) or LPSup primed), and THP1 (PMA primed) were stimulated with OCP and MSU at 250 μg ml−1, 500 μg ml−1 Alum and 200 μg ml−1 HZ. (a) The % XO and XDH activity was measured in BMDM cell lysates using the pterin assay; (b) RNA transcript level of XOR by qRT–PCR in P3C-primed BMDM. Expression levels were quantified using the 2ΔΔCT method, with Tbp as a reference gene. (c) Total XOR protein levels in P3C-primed BMDM measured by ELISA. (d) THP1 cells stimulated with OCP crystals and the CE, and supernatants blotted against anti-human XOR antibody or α-tubulin.
Figure 4 XOR was not modulated at RNA and protein levels. In vitro C57BL/6 BMDM (Pam3Cys (P3C) or LPSup primed), and THP1 (PMA primed) were stimulated with OCP and MSU at 250 μg ml−1, 500 μg ml−1 Alum and 200 μg ml−1 HZ. (a) The % XO and XDH activity was measured in BMDM cell lysates using the pterin assay; (b) RNA transcript level of XOR by qRT–PCR in P3C-primed BMDM. Expression levels were quantified using the 2ΔΔCT method, with Tbp as a reference gene. (c) Total XOR protein levels in P3C-primed BMDM measured by ELISA. (d) THP1 cells stimulated with OCP crystals and the CE, and supernatants blotted against anti-human XOR antibody or α-tubulin.CC BY · PubMed Central
Figure 5 Crystal-mediated XOR activation induces the PI3K–AKT–mTOR pathway and mitochondrial ROS production. In vitro BMDM (Pam3Cys primed), and THP1 cells (PMA primed) were pretreated with 200 μM febuxostat, 10 μM Ly294002, 10 μM Wortmannin, 10 μM AKTx, or Rapamycin (Rapa), and stimulated with OCP or MSU at 250 μg ml−1, or 500 μg ml−1 Alum. (a,b) IL1β protein secretion measured in BMDM. (c) Relative expression levels determined by ELISA of phosphorylated (p-) AKT (ser473) over total AKT levels in BMDM at 1 h. (d) THP1 cell extracts analysed for phosphorylated AKT (p-AKT) at ser473, and α-tubulin by western blot. Relative protein levels determined by band intensity quantification, and given as p-AKT over α-tubulin, normalized with unstimulated cells being 1. (e) Mitochondrial ROS detected by MitoSOX, results given as RFU at T=60 min over T=0. (f) Mitochondrial potential of BMDM was measured using the ratio of monomeric (Em525) to multimeric JC-10 (Em590). Experiments were performed at 6 h; data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance for all panels
Figure 5 Crystal-mediated XOR activation induces the PI3K–AKT–mTOR pathway and mitochondrial ROS production. In vitro BMDM (Pam3Cys primed), and THP1 cells (PMA primed) were pretreated with 200 μM febuxostat, 10 μM Ly294002, 10 μM Wortmannin, 10 μM AKTx, or Rapamycin (Rapa), and stimulated with OCP or MSU at 250 μg ml−1, or 500 μg ml−1 Alum. (a,b) IL1β protein secretion measured in BMDM. (c) Relative expression levels determined by ELISA of phosphorylated (p-) AKT (ser473) over total AKT levels in BMDM at 1 h. (d) THP1 cell extracts analysed for phosphorylated AKT (p-AKT) at ser473, and α-tubulin by western blot. Relative protein levels determined by band intensity quantification, and given as p-AKT over α-tubulin, normalized with unstimulated cells being 1. (e) Mitochondrial ROS detected by MitoSOX, results given as RFU at T=60 min over T=0. (f) Mitochondrial potential of BMDM was measured using the ratio of monomeric (Em525) to multimeric JC-10 (Em590). Experiments were performed at 6 h; data are representative of at least two experiments. Results are expressed as mean±s.e.m. Significance was determined at *P≤0.05, **P≤0.01, ***P≤0.005 and ****P≤0.0001 by analysis of variance for all panelsCC BY · PubMed Central
Figure 6 Crystal-mediated XOR activation induces the PI3K–AKT–mTOR pathway and mitochondrial ROS production. (a) Colocalization in BMDM of fluorescein isothiocyanate-labelled anti-XOR antibody, Mitotracker and counterstained with 4,6-diamidino-2-phenylindole (DAPI). Images visualized at × 630. Scale bars are indicated. Results are representative of several fields of view with similar results after 6 h of stimulation. (b) Autophagic vesicle formation in unstimulated BMDM after 2 h treatment were detected by LC3B Antibody labelled with TRITC, and counterstained with DAPI. Images were visualized at × 400 and are representative of several fields of view with similar results. (c) Corrected total cell fluorescence (CTCF) was calculated for each cell in multiple fields of view for LC2B/TRITC red fluorescence. Results are expressed as mean±s.e.m. and significance was determined at *P≤0.05 and ****P≤0.0001 by ANOVA. NP, not performed. NS, not significant.
Figure 6 Crystal-mediated XOR activation induces the PI3K–AKT–mTOR pathway and mitochondrial ROS production. (a) Colocalization in BMDM of fluorescein isothiocyanate-labelled anti-XOR antibody, Mitotracker and counterstained with 4,6-diamidino-2-phenylindole (DAPI). Images visualized at × 630. Scale bars are indicated. Results are representative of several fields of view with similar results after 6 h of stimulation. (b) Autophagic vesicle formation in unstimulated BMDM after 2 h treatment were detected by LC3B Antibody labelled with TRITC, and counterstained with DAPI. Images were visualized at × 400 and are representative of several fields of view with similar results. (c) Corrected total cell fluorescence (CTCF) was calculated for each cell in multiple fields of view for LC2B/TRITC red fluorescence. Results are expressed as mean±s.e.m. and significance was determined at *P≤0.05 and ****P≤0.0001 by ANOVA. NP, not performed. NS, not significant.CC BY · PubMed Central
Figure 7 Inhibition of XOR impairs IL1β secretion triggered by soluble inflammasome inducers and in vivo. In vitro C57BL/6 BMDM (Pam3Cys primed) pretreated with 200 μM febuxostat, N-acetyl cysteine (NAC), 10 μM Ly294002 or 10 μM AKTx inhibitor and stimulated with a crude extract of 1 μg ml−1 LPS, 2.5 μM nigericin or 5 mM ATP. (a) XO activity measured in cell extracts at 1 h. (b) IL1β protein secretion measured in BMDM at 6 h. (c) Mice injected intraperitoneally with LPSc with or without 1 mM Febuxostat for 6 h. Urate levels and IL1β were measured in cell-free washes (two pooled experiments). (d) IL1β protein secretion measured in BMDM after 15 min stimulation for ATP and 6 h for nigericin. Data are representative of at least two experiments. Results are expressed as mean±s.e.m. Statistical significance was determined at *P≤0.05, **P≤0.01 and ****P≤0.0001 by analysis of variance (b,d) or the t-test (a,c).
Figure 7 Inhibition of XOR impairs IL1β secretion triggered by soluble inflammasome inducers and in vivo. In vitro C57BL/6 BMDM (Pam3Cys primed) pretreated with 200 μM febuxostat, N-acetyl cysteine (NAC), 10 μM Ly294002 or 10 μM AKTx inhibitor and stimulated with a crude extract of 1 μg ml−1 LPS, 2.5 μM nigericin or 5 mM ATP. (a) XO activity measured in cell extracts at 1 h. (b) IL1β protein secretion measured in BMDM at 6 h. (c) Mice injected intraperitoneally with LPSc with or without 1 mM Febuxostat for 6 h. Urate levels and IL1β were measured in cell-free washes (two pooled experiments). (d) IL1β protein secretion measured in BMDM after 15 min stimulation for ATP and 6 h for nigericin. Data are representative of at least two experiments. Results are expressed as mean±s.e.m. Statistical significance was determined at *P≤0.05, **P≤0.01 and ****P≤0.0001 by analysis of variance (b,d) or the t-test (a,c).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Harris, J. et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J. Biol. Chem. 286, 9587–9597 (2011) . · DOI · Paper page

Cited by

Metadata

Authors
Ives, A., Nomura, J., Martinon, F., Roger, T., LeRoy, D., Miner, J. N., Simon, G., Busso, N., & So, A.
Affiliations
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of Lausanne (CH)
Corresponding author
So, Alexander
Venue
Nature Communications
Published
2015-03-24
Volume
6
Issue
1
Pages
6555-6555
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2049267620
Cited by
264
References
58
Citations by year
2026: 17 · 2025: 31 · 2024: 29 · 2023: 31 · 2022: 26 · 2021: 31 · 2020: 28 · 2019: 24 · 2018: 7 · 2017: 20 · 2016: 14 · 2015: 6
FWCI
6.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, other-oa)
  • IRIS (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310040, 130085)
  • Teijin Pharma
  • Institute of Rheumatology Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords
xanthine oxidoreductase, xanthine oxidase, NLRP3 inflammasome, IL-1β secretion, macrophages, reactive oxygen species, mitochondrial reactive oxygen species, PI3K/Akt signaling, caspase-1, uric acid, ATP, lipopolysaccharide, crystal-induced inflammation, inflammasome activation
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Autophagy, Calcium, Calcium Phosphates, Carrier Proteins, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Monocytes, Peritonitis, Phosphorylation, Uric Acid, Xanthine Dehydrogenase, Xanthine Oxidase, Blotting, Western, Signal Transduction, Reactive Oxygen Species, Reverse Transcriptase Polymerase Chain Reaction, Caspase 1, Proto-Oncogene Proteins c-akt, Mice, Interleukin-1beta, Gene Knockdown Techniques, Real-Time Polymerase Chain Reaction, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.